...A. The shareholder list shows that as of the record date, there were 494,097,056 shares of common stock outstanding and entitled to vote at this meeting. B. Earlier this week, we announced the completion of the FDA review of Bovaer, the first-in-class methane-reducing feed ingredient for US dairy farmers, signaling our ability to commercialize the product. C. Our focus on consistent high-impact innovation while stabilizing the base business, allowed for a return on a constant currency revenue growth last year. D. Our base business is growing, operating cash flow is improving, and contributions from new products are exceeding expectations....
